WASHINGTON - Federal regulators Thursday ordered reviews of dozens of ongoing patient studies of the prescription painkillers Celebrex and Bextra in light of findings that both drugs may increase the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results